These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

449 related items for PubMed ID: 15241294

  • 1. What is the rationale for new treatment strategies in Alzheimer's disease?
    Rogawski MA.
    CNS Spectr; 2004 Jul; 9(7 Suppl 5):6-12. PubMed ID: 15241294
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Therapy of Alzheimer disease].
    Kovács T.
    Neuropsychopharmacol Hung; 2009 Mar; 11(1):27-33. PubMed ID: 19731816
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease.
    Rogawski MA, Wenk GL.
    CNS Drug Rev; 2003 Mar; 9(3):275-308. PubMed ID: 14530799
    [Abstract] [Full Text] [Related]

  • 11. In vitro galantamine-memantine co-application: mechanism of beneficial action.
    Zhao X, Marszalec W, Toth PT, Huang J, Yeh JZ, Narahashi T.
    Neuropharmacology; 2006 Dec; 51(7-8):1181-91. PubMed ID: 17011596
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pharmacology of acetylcholinesterase inhibitors and N-methyl-D-aspartate receptors for combination therapy in the treatment of Alzheimer's disease.
    Geerts H, Grossberg GT.
    J Clin Pharmacol; 2006 Jul; 46(7 Suppl 1):8S-16S. PubMed ID: 16809810
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Alzheimer drugs for mild cognitive impairment].
    Fellgiebel A.
    Neuropsychiatr; 2007 Jul; 21(3):230-3. PubMed ID: 17915184
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis.
    Tan CC, Yu JT, Wang HF, Tan MS, Meng XF, Wang C, Jiang T, Zhu XC, Tan L.
    J Alzheimers Dis; 2014 Jul; 41(2):615-31. PubMed ID: 24662102
    [Abstract] [Full Text] [Related]

  • 18. Comparison table: drugs for Alzheimer's disease.
    Med Lett Drugs Ther; 2017 Sep 25; 59(1530):e160-e161. PubMed ID: 28922344
    [No Abstract] [Full Text] [Related]

  • 19. A review on cholinesterase inhibitors for Alzheimer's disease.
    Anand P, Singh B.
    Arch Pharm Res; 2013 Apr 25; 36(4):375-99. PubMed ID: 23435942
    [Abstract] [Full Text] [Related]

  • 20. [Cholesterol inhibitor and memantine in symptomatic dementia therapy].
    Rodda J, Carter J.
    Praxis (Bern 1994); 2013 Feb 27; 102(5):293-300; discussion 298-9. PubMed ID: 23446240
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.